|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0008976,
umls-concept:C0016360,
umls-concept:C0016617,
umls-concept:C0019134,
umls-concept:C0029237,
umls-concept:C0035168,
umls-concept:C0087111,
umls-concept:C0239307,
umls-concept:C0574032,
umls-concept:C0685938,
umls-concept:C1516225,
umls-concept:C1521808,
umls-concept:C1522673,
umls-concept:C1527249,
umls-concept:C1556094
|
|
pubmed:issue |
9117
|
|
pubmed:dateCreated |
1998-9-25
|
|
pubmed:abstractText |
There is conflicting evidence on the efficacy of regional adjuvant chemotherapy, via portal-vein infusion (PVI), after resection of colorectal cancer. We undertook a randomised controlled multicentre trial to investigate the efficacy of PVI (500 mg/m2 fluorouracil plus 5000 IU heparin daily for 7 days).
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
pubmed-author:ApoloneGG,
pubmed-author:CouvreurM LML,
pubmed-author:CurranDD,
pubmed-author:De WaeleBB,
pubmed-author:DockPP,
pubmed-author:LabiancaRR,
pubmed-author:LasserPP,
pubmed-author:MarsoniSS,
pubmed-author:NakajimaTT,
pubmed-author:NittsRR,
pubmed-author:PectorJ CJC,
pubmed-author:RauscheckerHH,
pubmed-author:RougierPP,
pubmed-author:SahmoudTT,
pubmed-author:WilkBB
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
6
|
|
pubmed:volume |
351
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1677-81
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9734883-Aged,
pubmed-meshheading:9734883-Anticoagulants,
pubmed-meshheading:9734883-Antimetabolites, Antineoplastic,
pubmed-meshheading:9734883-Chemotherapy, Adjuvant,
pubmed-meshheading:9734883-Colonic Neoplasms,
pubmed-meshheading:9734883-Disease Progression,
pubmed-meshheading:9734883-Drug Combinations,
pubmed-meshheading:9734883-Female,
pubmed-meshheading:9734883-Fluorouracil,
pubmed-meshheading:9734883-Heparin,
pubmed-meshheading:9734883-Humans,
pubmed-meshheading:9734883-Infusions, Intravenous,
pubmed-meshheading:9734883-Liver Neoplasms,
pubmed-meshheading:9734883-Male,
pubmed-meshheading:9734883-Portal Vein,
pubmed-meshheading:9734883-Proportional Hazards Models,
pubmed-meshheading:9734883-Prospective Studies,
pubmed-meshheading:9734883-Rectal Neoplasms,
pubmed-meshheading:9734883-Survival Analysis,
pubmed-meshheading:9734883-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research.
|
|
pubmed:affiliation |
Hôpital Ambroise-Paré, Boulogne, France. philippe.rougier@apr.ap-hop-paris.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Multicenter Study
|
